The Zacks Analyst Blog Highlights: Freescale Semiconductor, IQ Merger Arbitrage ETF, Credit Suisse Merger Arbitrage Index ETN and ProShares Merger ETF - Press Releases

A generic image of a stock chart on a display
Credit: Shutterstock photo

For Immediate Release

Chicago, IL - April 09, 2015 - announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stock and ETFs recently featured in the blog include the Freescale Semiconductor ( FSL - Free Report ), IQ Merger Arbitrage ETF ( MNA - Free Report ), Credit Suisse Merger Arbitrage Index ETN ( CSMA - Free Report ) and ProShares Merger ETF ( MRGR - Free Report ).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .

Here are highlights from Wednesday's Analyst Blog:

Bet on M&A Frenzy with These ETFs and Stocks

M&A (Mergers and Acquisitions) - now the major impetus for the stock market - is not showing any sign of slowing down. This is primarily thanks to low interest rates, cheap borrowing cost, healthy cash reserves, hunt for higher growth and strong dollar.

According to the latest data released by Dealogic , the value of M&A across the globe rose 23% year over year in the first quarter of this year to $902.2 billion. This marks the most energetic start and the highest in eight years when the value reached $1.08 trillion. U.S. made the largest first-quarter deals since 2007, making up for nearly 46% of the value while Europe accounted for 24% of the deal value with the best first quarter since 2011.

In terms of sectors, healthcare led the way in the global M&A space with a $126.5 billion deal value, closely followed by $113 billion for real estate, and $84.3 billion for technology. In fact, $10 billion plus mega deals totaled 14, the highest number since 1Q 2006 (read: Healthcare ETFs Rally on Monday Merger Mania ).

Some Hot Brewing Deals

The largest and hottest deal announced in the first quarter was the $45.4 billion takeover of the U.S. packaged food giant Kraft Foods Group by the ketchup maker H.J. Heinz. The transaction will create North America's third-largest food and beverage company and the fifth largest food and beverage company in the world with annual revenue in excess of $28 billion and. The merger, pending approval from Kraft shareholders and regulatory bodies, is expected to close in the second half of the year (read: Kraft Food Buyout Put These ETFs in Focus ).

Sizzling deals were also announced in the healthcare space with the largest being the AbbVie bid to acquire Pharmacyclics for nearly $21 billion. AbbVie expects to finance the deal using a combination of existing cash, new debt and stock. The deal is expected to close in mid 2015. The other two large deals were the $17-billion Pfizer offer to buy Hospira and $15.9-billion takeover of Salix Pharmaceuticals by Valeant Pharmaceuticals.

Meanwhile, the largest U.S. health insurer UnitedHealth Group agreed to merge with the fourth-largest U.S. pharmacy-benefit management company, Catamaran Corp, for $13.4 billion, including debt. The transaction, pending approvals from Catamaran shareholders and regulators, is expected to close in the fourth quarter of 2015.

Apart from these, NXP Semiconductors agreed to merge with the smaller peer Freescale Semiconductor ( FSL - Free Report ) in the semiconductor corner of the broad technology space for $11.8 billion in cash and stock. The total value of the deal is $16.7 billion, including debt. The merged entity will have an enterprise value of over $40 billion and annual revenues of over $10 billion, and would be the world's eighth-largest chipmaker (read: Nasdaq Hits 5,000 on Tech Mergers: Semiconductor ETFs Surge ).

How to Tap?

Investors could easily take advantage of this surge in deals by either employing the merger arbitrage strategy to their portfolio or investing in some M&A advisory firms that reap huge revenues.

Merger Arbitrage Strategy

This strategy looks to tap the price differential (or spread) between the stock price of the target company after the public announcement of its proposed acquisition and the price offered by the acquirer to pay for the stocks of the target company. This is especially true given that investors should go long on the target or acquired company and short on the acquiring company. When the deal is completed, shares of the target company will increase to the full deal price (in some cases slightly below the deal price), giving investors a nice profit.

While investors could capitalize on merger arbitrage by trading in a particular target stock, the ETFs provide diversified exposure in the basket form with lower risk. The most popular ETF in this space - IQ Merger Arbitrage ETF ( MNA - Free Report ) - is worth considering. The fund offers capital appreciation by investing in global companies for which there have been public announcements of takeovers while at the same time provides short exposure to global equities as a partial equity market hedge. This is done by tracking the IQ Merger Arbitrage Index (see: all Hedge Fund ETFs here ).

Holding 67 securities in its basket, the fund allocates higher to Morgan Stanley ILF/TREAS/INST and KRFT on the long side, making up for over one-fifth of the share. The product has amassed $112.9 million in its asset base and trades in average volume of less than 32,000 shares a day. Expense ratio came in at 76 basis points a year. The ETF has added about 3.6% in the year-to-date time frame.

While investors have a couple more option in this space - Credit Suisse Merger Arbitrage Index ETN ( CSMA - Free Report ) and ProShares Merger ETF ( MRGR - Free Report ) - they have failed to garner enough investors' interest, gathering just $6.7 million and $5.5 million in AUM, respectively. Further, both funds are illiquid, increasing their total cost of trading in the form of a wide bid/ask spread beyond the expense ratio of 0.55% and 0.75%, respectively. CSMA is almost flat so far in the year while MRGR added nearly 1.9%.

M&A Advisers

Wall Street banks have been the biggest beneficiaries of heightened merger activity. Goldman Sachs led the way higher in the lucrative M&A advisory business, followed by JPMorgan and Morgan Stanley. These have gained $752 million, $466 million, and $404 million, respectively, in revenues from deals advisory in Q1 (read: 3 Financial ETFs for Dividend and Growth ).

The trio has a Zacks Rank #3 (Hold) and are scheduled to report earnings in the next two weeks.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today .

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


IQ-MERGER ARB (MNA): ETF Research Reports

CS-MRGR ARB IDX (CSMA): ETF Research Reports

PRO-MERGER (MRGR): ETF Research Reports

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More